Partner with us and leverage our technology for the development of the next wave of superior protein conjugates and Antibody-Drug-Conjugates!
Looking to fast track your development of next generation bioconjugates, staying ahead of your competitors?
With the complete freedom to choose where on the protein, we conjugate and optimize for:
• Stability,
• Aggregation,
• Superior efficacy,
• Therapeutic window
... and more!
The process is simple!
1. Get in touch with us (message us here or visit our website).
2. After you let us know about your protein of interest, we produce different site-specific conjugate versions for you.
3. They are shipped either to you or your CRO.
4. You collect the data you need.
5. Go or no-go decision.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Plöcking 1 3400, Klosterneuburg,lower Austria 3400,austria
- Industry
- Biotechnology
- Website
- valanx.bio
- Keywords
- Bioconjugation, Site-specific conjugation, PEGylation, Biotechnology, Research and Development, ADCs, Novel format conjugates, Radioconjugates, Next generation bioconjugates, Site-agnostic conjugation.
- HQ
- Klosterneuburg, Lower Austria
Valanx Biotech Questions
Valanx Biotech's website is valanx.bio
Valanx Biotech's LinkedIn profile is https://at.linkedin.com/company/valanxbiotech
Valanx Biotech has
15 employees.
View email and phone details for 15
employees at Valanx Biotech.
Valanx Biotech's industry is
Biotechnology
Valanx Biotech's top competitors are
Proxygen,
Ribbon Bio,
Bit.bio Discovery,
Oncoone,
Sarcura,
Solgate,
Biotech Austria,
Lexogen,
Myllia Biotechnology,
Hookipa Pharma Inc..
Valanx Biotech's categories are Biotechnology
Valanx Biotech's founding year is 2017
